"Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease." by Kenneth Tran

Selected Works of Brant W. Ullery, MD, MBA, FACS, FSVS

Article

Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.

Annals of Vascular Surgery (2016)

Kenneth Tran, Stanford University
Brant W. Ullery, Stanford University
Marcus R. Kret, Stanford University
Jason T. Lee, Stanford University

Link

Disciplines

Medicine and Health Sciences,
Radiology and
Surgery

Publication Date

July 1, 2016

DOI

10.1016/J.AVSG.2016.08.006

Citation Information

Kenneth Tran, Brant W. Ullery, Marcus R. Kret and Jason T. Lee. "Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease." Annals of Vascular Surgery Vol. 38 (2016) p. 90 - 98
Available at: http://works.bepress.com/brantw-ullery/30/